Profile data is unavailable for this security.
About the company
Cathay Biotech Inc is a China-based company mainly engaged in the research and development, production and sales of new bio-based materials. The Company's main products include a series of bio-based long-chain dibasic acids (DC10-DC18), bio-based pentamethylenediamine and a series of bio-based polyamides. The Company's brands include Taylon mainly used in the textile field and ECOPENT mainly used in the engineering materials field. The Company's product application areas include civil silk field, industrial silk field, non-woven fabric field, engineering plastics field, and others. The Company is developing bio-based polyamide thermoplastic composite materials, which can be used in new energy equipment, transportation logistics, building decoration and other industries.
- Revenue in CNY (TTM)2.76bn
- Net income in CNY397.82m
- Incorporated2000
- Employees1.80k
- LocationCathay Biotech Inc4th Floor, Building 51690 Cailun Road, China (Shanghai)Pilot Free Trade ZoneSHANGHAI 201114ChinaCHN
- Phone+86 2 150801916
- Fax+86 2 150801386
- Websitehttps://www.cathaybiotech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jiangsu Yangnong Chemical Co Ltd | 10.22bn | 1.23bn | 22.45bn | 3.50k | 18.22 | 2.16 | -- | 2.20 | 3.03 | 3.03 | 25.15 | 25.51 | 0.6267 | 6.31 | 4.32 | 2,919,915.00 | 7.55 | 11.33 | 11.91 | 19.40 | 23.44 | 25.70 | 12.04 | 12.08 | 0.9833 | -- | 0.2033 | 19.61 | -27.41 | 5.98 | -12.77 | 9.82 | 15.10 | 5.63 |
| Kingfa Sci&Tech Co Ltd | 54.11bn | 515.42m | 23.39bn | 10.63k | 45.82 | 1.34 | -- | 0.4322 | 0.1936 | 0.1936 | 20.27 | 6.60 | 0.8702 | 7.38 | 7.67 | 5,091,224.00 | 0.008 | 4.63 | 0.013 | 7.60 | 10.61 | 16.53 | 0.0091 | 4.98 | 0.7999 | 1.13 | 0.6086 | 39.59 | 18.63 | 13.62 | -84.10 | -12.68 | 28.77 | 0.00 |
| Skshu Paint Co Ltd | 12.21bn | 29.33m | 24.11bn | 9.83k | 1,023.95 | 8.70 | -- | 1.97 | 0.0447 | 0.0447 | 23.26 | 5.26 | 0.7942 | 11.09 | 2.43 | 1,241,958.00 | 0.1718 | 2.12 | 0.5443 | 6.48 | 28.62 | 30.83 | 0.2163 | 2.13 | 0.6997 | 0.581 | 0.6905 | 36.26 | 10.03 | 28.33 | -47.33 | -4.85 | 16.84 | 3.80 |
| Hubei Xingfa Chemicals Group Co Ltd | 28.23bn | 1.76bn | 26.95bn | 14.59k | 16.74 | 1.27 | -- | 0.9548 | 1.46 | 1.46 | 23.44 | 19.25 | 0.6222 | 9.59 | 14.63 | 1,935,001.00 | 3.83 | 8.09 | 5.52 | 13.68 | 18.04 | 22.93 | 6.15 | 11.72 | 0.3891 | 7.45 | 0.3898 | 21.95 | -7.28 | 9.50 | -76.44 | 31.74 | 20.59 | 24.57 |
| Cathay Biotech Inc | 2.76bn | 397.82m | 27.05bn | 1.80k | 68.00 | 2.38 | -- | 9.79 | 0.6819 | 0.6819 | 4.74 | 19.52 | 0.1489 | 1.38 | 8.89 | 1,532,872.00 | 2.12 | 4.05 | 3.26 | 5.59 | 30.38 | 37.19 | 14.24 | 25.08 | 2.33 | -- | 0.0797 | 30.03 | -13.39 | 3.77 | -33.75 | -4.70 | 30.80 | -- |
| Tongkun Group Co Ltd | 96.95bn | 900.15m | 28.86bn | 33.66k | 32.10 | 0.7934 | -- | 0.2977 | 0.3729 | 0.3729 | 40.55 | 15.09 | 0.8915 | 8.91 | 85.95 | 2,880,011.00 | 0.8414 | 4.49 | 1.61 | 7.64 | 4.11 | 7.13 | 0.9438 | 4.72 | 0.4155 | 2.05 | 0.6042 | 15.64 | 33.30 | 14.71 | 539.10 | -17.77 | 31.29 | -18.56 |
Data as of Nov 21 2024. Currency figures normalised to Cathay Biotech Inc's reporting currency: Chinese Yuan Renminbi CNY
11.64%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| HBM Partners AG (Investment Management)as of 31 Mar 2024 | 35.62m | 6.11% |
| China Asset Management Co., Ltd.as of 30 Sep 2023 | 16.79m | 2.88% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 3.91m | 0.67% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 3.84m | 0.66% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 2024 | 2.44m | 0.42% |
| The Vanguard Group, Inc.as of 06 Nov 2024 | 1.37m | 0.23% |
| Bosera Asset Management Co., Ltd.as of 07 Nov 2024 | 1.34m | 0.23% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2024 | 1.18m | 0.20% |
| CPIC Fund Management Co. Ltd.as of 30 Jun 2024 | 805.88k | 0.14% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2024 | 635.44k | 0.11% |
More ▼
Data from 30 Jun 2024 - 11 Nov 2024Source: FactSet Research Systems Inc.
